Vistaril® (hydroxyzine), Xyzal® (levocetirizine) – Safety communication
November 8, 2016, the FDA approved a new update to the Precautions section of the Vistaril (hydroxyzine pamoate) drug label pertaining to the risk of acute generalized exanthematous pustulosis (AGEP).
Download PDF
